Prot# CP12-0710: An Open Label, Multicenter, Phase 2 Study Evaluating the Safety and Efficacy of IMC-1121B as First-Line Monotherapy in Patients with Unresectable Hepatocellular Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date5/8/08 → 5/8/11

Funding

  • ImClone Systems Incorporated (CP12-0710)